Gujarat Terce Laboratories Limited (BOM:524314)

India flag India · Delayed Price · Currency is INR
50.55
+2.31 (4.79%)
At close: Jul 29, 2025
4.79%
Market Cap375.10M
Revenue (ttm)501.95M
Net Income (ttm)-9.79M
Shares Out7.42M
EPS (ttm)-1.32
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,695
Average Volume5,799
Open48.00
Previous Close48.24
Day's Range47.11 - 52.00
52-Week Range45.15 - 94.90
Beta0.59
RSI49.23
Earnings DateAug 8, 2025

About BOM:524314

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company’s products include branded generic pharmaceutical covering various therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides its products in various forms, including tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, and Aziter brands. Gujarat Ter... [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 286
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524314
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.